Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation
Heart BMJ
MARCH 22, 2024
Methods This was a retrospective analysis of the Verona Valvular Heart Disease Registry (Italy) including 250 patients (83 (80–86) years, 53% female) with severe AS who underwent TAVI between 2019 and 2021. The primary endpoint was the composite of cardiovascular death and rehospitalisation for heart failure (HF).
Let's personalize your content